Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a customized breastfeeding class boost Mom-Baby bonding?

NCT ID NCT07478341

Knowledge-focused Sponsor: Emel GÜÇLÜ CİHAN Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Aug 27, 2026 · Updated 2 times

Summary

This study tests whether a personalized hybrid breastfeeding education program—combining face-to-face sessions with online materials—given in late pregnancy can improve mother-baby bonding and breastfeeding success in first-time mothers. Sixty-four women will be randomly assigned to either the special education or standard care. Researchers will measure bonding and breastfeeding confidence using questionnaires.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Individualized hybrid breastfeeding education (face-to-face sessions plus online materials and support)
What this could lead to
If successful, this approach could help first-time mothers feel more confident and bond better with their babies, leading to longer and more successful breastfeeding.
What could go wrong
This is a small, early-stage study with only 64 participants, so results may not apply to all mothers. The outcomes rely on self-reported surveys, which can be biased.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 64 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jan 2026

Expected to finish

Sep 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 35 years

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Aged 18-35 years, At 36 weeks of gestation or later, Experiencing their first pregnancy (primiparous), Having a singleton pregnancy, Able to read and write in Turkish and capable of communication, Having access to a smartphone or the internet, Free from any physical or mental health problems that would prevent participation in the education, Willing to voluntarily participate in the study and provide written informed consent. Exclusion Criteria: Presence of chronic physical illness or pregnancy complications (e.g., preeclampsia, gestational diabetes), Multiple pregnancy, Gestation earlier than 36 weeks, Inability to actively participate in the education due to communication barriers or cognitive impairment, Lack of access to a smartphone or the internet, Failure to attend any stage of the educational program or voluntary withdrawal from the study, Refusal to participate in the study or failure to sign the informed consent form.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Breast feeding are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Breast Feeding

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Breast feeding Exclusive breast feeding Maternal-fetal attachment Primiparity

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Elbistan Devlet Hastanesi

    RECRUITING

    Elbistan, Kahramanmaraş, 46040, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.